Pre-clinical models of infectious diseases - task area c
Active Awarded Last action
- Contract number
- 75N93024D00016
- Awardee
-
Mimetas US Inc. UEI QGP7JLTGMAK9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Pre-Clinical Models of Infectious Diseases Pre-Solicitation · NIHAI75N93023R00003 · Posted Oct 21, 2022
- Last date to order 32% complete
- IDV ceiling
- $146,300,000.00
- Maximum order
- $146,300,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 76 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is for an Indefinite Delivery Contract with a ceiling value of $146,300,000 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is focused on providing pre-clinical models of infectious diseases to support research, development, and evaluation of medical countermeasures such as therapeutics, vaccines, and diagnostics.
The contract has a single award to Mimetas US Inc., a self-certified small disadvantaged business based in Maryland. It covers four task areas: (A) small animal models, (B) non-human primate models, (C) animal replacement and non-traditional animal models, and (D) generation and distribution of specialized reagents. The contract aims to develop and refine animal and animal replacement models to evaluate candidate countermeasures against a range of infectious agents, including those with pandemic potential and drug-resistant pathogens. The period of performance is 7 years from the July 2024 award date.
Quick answers
Who was awarded contract 75N93024D00016?
75N93024D00016 was awarded to Mimetas US Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2024.
How much is contract 75N93024D00016 worth?
75N93024D00016's own ceiling is $146,300,000. A single order can be worth up to $146,300,000.
Who can order from contract 75N93024D00016?
75N93024D00016 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93024D00016 part of a contract vehicle?
Yes. 75N93024D00016 is part of Pre-Clinical Models of Infectious Diseases.
Was contract 75N93024D00016 competed?
The extent of competition for 75N93024D00016 was full and open competition. The government received 76 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV